Dr. Phillip Scherer's Study Group (IMAGE)

UT Southwestern Medical Center

Dr. Phillip Scherer's Study Group

Caption

A study led by Dr. Phillip Scherer (l-r), Jonathan Xia, and Dr. William Holland determined that reducing concentrations of the fatty molecule ceramide improves insulin sensitivity, offering potential as a new therapy for diabetes.

Credit

UT Southwestern

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.